News Briefs

Orna Therapeutics fetches $80m Series A

Orna Therapeutics, a biotechnology company, has raised $80 million in Series A financing.

24 February 2021

Orna Therapeutics, a biotechnology company, has raised $80 million in Series A financing. MPM Capital, Taiho Ventures, and F2 Ventures led the round.

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Register now